UBS Says the Market Is Pricing Lockheed Like a Bond — Most of the Street Still Disagrees

UBS has upgraded Lockheed Martin to Buy with a price target of $674 against a share price of about $536, an implied upside of roughly 26%. Analyst Gavin Parsons argues that consensus earnings estimates for 2028 could prove too low by a double-digit percentage, and that investors have been treating the defence contractor as a slow-growing income stock when the underlying business is accelerating. The stock is green for the year but well below its March high, and trades at roughly a 15% discount to the S&P 500.

The argument rests on production rather than orders. Parsons models a 9% compound annual revenue growth rate through 2028, driven by missiles and munitions alongside F-35 sustainment work, the CH-53K helicopter and the Trident programme. His point is that the market has already priced in demand for munitions, which is hardly a secret in the current environment, but has not paid for the possibility that Lockheed produces them faster and more consistently than expected. On cash, he now models 38% growth in free cash flow between 2025 and 2030, enough to fund a $1 billion pension over-earn even with heavier capital spending and limits on buybacks.

The Street is not persuaded. Of the 24 analysts covering Lockheed, 13 rate it a Hold and only 10 call it a Buy or Strong Buy, which is an unusually cautious spread for a company with a full order book. The scepticism has a basis: defence revenue converts slowly, fixed-price development contracts have produced charges across the sector, and a growth rate that depends on ramping physical production lines is exposed to the same labour and supply-chain constraints that have delayed deliveries for the past three years. A thesis built on manufacturing throughput can be undone by a single supplier.

What settles the argument is the delivery data rather than the backlog figure. The numbers worth following are quarterly missile and munitions deliveries against plan, F-35 sustainment margins, and free cash flow conversion in the next two reports. If output rises on schedule, the discount to the wider market narrows on its own. If it does not, the Hold ratings will look like the more accurate reading.